RETRACTED: ORIENT-3: A Randomized, Open-Label, Phase III Study of Sintilimab Versus Docetaxel in Previously Treated Advanced/metastatic Squamous Non-Small Cell Lung Cancer (Sqnsclc)
Yuan Shi,Lin Wu,Xinmin Yu,Puyuan Xing,Jianying Zhou,A. Wang,J. Shi,Yi Hu,Z. Wang,Gary An,Yiman Fang,Shuai Sun,Caicun Zhou,C. Wang,F. Ye,X. Li,J. Wang,M. Wang,Y. Liu,Yanqiu Zhao
DOI: https://doi.org/10.1016/j.annonc.2020.10.517
IF: 51.769
2020-01-01
Annals of Oncology
Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article was retracted at the request of the authors. The authors of this abstract have advised that full agreement between authors and sponsors on publication of the abstract has not been reached and they are therefore unable to publish this data at present.